| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.4 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |